NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced ...

Blue-chip tech stocks are a big part of President Donald Trump's portfolio, according to his latest financial disclosures.

Syndax Pharmaceuticals , a clinical-stage biopharmaceutical company focusing on cancer treatments, exemplified the challenges of accurately valuing high-growth biotech companies. When our Fair Value ...

Also Read: FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host Disease, A Post-Transplant Complication JPMorgan says that, on average, surveyed physicians treated 8 KMT2A acute ...

Syndax Pharmaceuticals traded as high as $13.51 and last traded at $13.84. 164,424 shares were traded during mid-day trading, a decline of 89% from the average session volume of 1,439,839 shares ...

Write to [email protected] Syndax Pharmaceuticals NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

The Revitalising the PNG Dictionary of Biography (PNGDB) Project is an attempt to celebrate Papua New Guineans from various sectors of society who have contributed to progressing the nation’s ...